Ovarian Cancer Drugs Market
Bevacizumab is a drug that blocks the blood supply to the cancer cells, thus slowing down the growth and spread of the tumor. Olaparib is a PARP inhibitor, a type of targeted therapy that blocks an enzyme that helps the cancer cells repair their DNA. Rucaparib is also a PARP inhibitor, and has been shown to be effective in treating advanced ovarian cancer.
Radiation therapy is another option for treating ovarian cancer drugs. This type of therapy uses high-energy radiation to kill cancer cells. Radiation therapy is typically used after surgery to kill any remaining cancer cells and prevent the cancer from returning.
Read More:
